HARTGROVE HOSPITAL — History
CCN 144026 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$71M
Latest Revenue (FY2022)
+15.7%
Revenue CAGR (3yr)
34.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $53M | $62M | $71M | +13.8% | +15.7% |
| Operating Expenses | $40M | $45M | $46M | +3.0% | +6.8% |
| Operating Margin | 23.4% | 27.9% | 34.8% | +24.6% | +21.9% |
| Net Income | $12M | $17M | $25M | +41.8% | +41.1% |
| Licensed Beds | 160 | 160 | 160 | +0.0% | +0.0% |
| Total Patient Days | 47,318 | 49,848 | 49,588 | -0.5% | +2.4% |
| Medicare Day % | 8% | 5% | 4% | -9.5% | -28.3% |
| Medicaid Day % | 12% | 4% | 4% | -10.2% | -45.5% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +33.9% ($53M → $71M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+15.7%
This Hospital
+7.6%
State Avg
Latest Margin
34.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $80M | 40.5% |
| FY2024 (proj) | $88M | 46.2% |
| FY2025 (proj) | $97M | 51.8% |